Matthew has been diagnosed with cancer and doctors estimate that he has roughly 5 months to live. From an economic standpoint, which best explains why Matthew might be more likely than a healthy person to take a risky experimental drug? His sunk costs are fewer than those of healthy people. His opportunity cost is lower than that of healthy people. His sunk costs are more than those of healthy people. 0000 His opportunity cost is higher than that of healthy people